Abstract
Purpose of the study — to conduct a comparative analysis of the auxological and hormonal parameters of patients with growth deficiency due to small for gestation age and growth hormone deficiency. Material and methods. We examined 84 prepubertal children (55 boys and 29 girls) with short stature. 50 of them were SGA children, other 34 children had growth hormone deficiency. All patients had two stimulation tests (insulin, clonidine) to check the growth hormone function. All patients were euthyroid on the basis of their TSH serum level within the normal range. They did not receive treatment with recombinant growth hormone (rGR) previously. Levels of GH, IGF‑1 were investigated by enzyme-linked immunosorbent assay using Immulate 2000 XPi kits. The levels of TSH, T4 free, IGF-BP‑3 were investigated by the immunoradiometric method using standard kits (Immunotech® kit, Chech Republic). Results. All SGA children with short stature had a significant decrease in length and body weight at birth compared to children with isolated somatotropic deficiency with the same gestational age. In all examined patients persisted the lack of growth and body weight. The degree of decreasing in growth, bone age, growth rate and stage of puberty in all examined patients did not significantly differ. In the majority (68,0%) of SGA patients without a «spontaneous catch-up growth», an adequate stimulated release of GH was recorded, however, such children remained significantly lack in growth and body weight. In others SGA patients (32%) and in isolated GH deficiency patients, a decrease in the stimulatory GH release was established, indicating a GH deficiency. In all examined children, a decrease in serum IGF‑1 and IGF-BP‑3 levels was observed. The decrease in the IGF-BP‑3 level was the same in patients of all groups, however, a significant decrease in the IGF‑1 level was observed in children with growth hormone deficiency compared to the SGA patients with GH deficiency (p<0.05). Conclusions. SGA patients who do not have a «spontaneous growth» can experience both normal and reduced rates of stimulated growth hormone and reduced IGF‑1 and IGF-BP‑3 levels. Deficiency of growth, body weight, decrease in the IGF‑1 and IGF-BP‑3 levels persist for a long time after the birth of the baby.
References
Clayton PE, Cianfarani S, Czernichow P, Johannsson G, Rapaport R, Rogol A. Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Paediatric Endocrinology and the Growth Hormone Research Society. J Clin Endocrinol Metab. 2007 Mar; 92 (3): 804-10. doi: 10.1210/jc.2006-2017
Karlberg J, Albertsson-Wikland K. Growth in full-term small-forgestational-age infants: from birth to final height. Pediatr Res. 1995 Nov; 38(5):733-9. Doi: 10.1203/00006450-199511000-00017
Jancevska A, Tasic V, Damcevski N, Danilovski D, Jovanovska V, Gucev Z. Children born small for gestational age (SGA). Prilozi. 2012; 33(2):47-58. PMID: 23425869
Slancheva B, Mumdzhiev H. Small for gestational age newborns — definition, etiology and neonatal treatment. Akush. Ginekol. (Sofiia). 2013; 52(2):25-32. PMID: 23807977
Campisi SC, Carbone SE, Zlotkin S. Catch-Up Growth in Full-Term Small for Gestational Age Infants: A Systematic Review. Adv. Nutr. 2019 Jan 1; 10(1):104-111. doi: 10.1093/advances/nmy09
Finken MJJ, van der Steen M, Smeets CCJ, Walenkamp MJE, de Bruin C, Hokken-Koelega ACS, Wit JM. Children Born Small for Gestational Age: Differential Diagnosis, Molecular Genetic Evaluation, and Implications. Endocr. Rev. 2018 Dec 1; 39(6):851-894. doi:10.1210/er.2018-00083.
Tachibana M, Nakayama M, Ida S, Kitajima H, Mitsuda N, Ozono K. Pathological examination of the placenta in small for gestational age (SGA) children with or without postnatal catch-up growth. J. Matern. Fetal. Neonatal Med. 2016 Mar; 29(6):982-6. doi:10.3109/14767058.2015.1029911.
Liu Q, Yang H, Sun X, Li G. Risk factors and complications of small for gestational age. Pak. J. Med. Sci. 2019 Sep-Oct; 35(5):1199-1203. doi:10.12669/pjms.35.5.253.
Hu Z, Tang L, Xu HL. Maternal Vitamin D Deficiency and the Risk of Small for Gestational Age: A Meta-analysis. Iran. J. Public Health. 2018 Dec; 47(12):1785-1795. PMID: 30788292
Zanelli SA, Rogol AD. Short children born small for gestational age outcomes in the era of growth hormone therapy. Growth Horm. IGF Res. 2018 Feb; 38:8-13. doi: 10.1016/j.ghir.2017.12.013
David A, Hwa V, Metherell LA, Netchine I, Camacho-Hübner C, Clark AJ, Rosenfeld RG, Savage MO. Evidence for a continuum of genetic, phenotypic and biochemical abnormalities in children with growth hormone insensitivity. Endocrine Reviews 2011. 32 472-497. doi:10.1210/er.2010-0023
Işık E, Haliloglu B, van Doorn J, Demirbilek H, Scheltinga SA, Losekoot M, Wit JM. Clinical and biochemical characteristics and bone mineral density of homozygous, compound heterozygous and heterozygous carriers of three novel IGFALS mutations. European Journal of Endocrinology 2017. 176 657-667. doi: 10.1530/EJE‑16-0999
Leung KC, Doyle N, Ballesteros M, Waters MJ, Ho KK. Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation. Journal of Clinical Endocrinology and Metabolism 2000. 85 4712-4720. doi: 10.1210/jcem.85.12.7017
Purandare A, Co Ng L, Godil M, Ahnn SH, Wilson TA. Effect of hypothyroidism and its treatment on the IGF system in infants and children. Journal of Pediatric Endocrinology and Metabolism 2003. 16 35-42. doi: 10.1515/jpem.2003.16.1.35
Meinhardt UJ, Ho KK. Modulation of growth hormone action by sex steroids. Clinical Endocrinology 2006. 65 413-422. doi: 10.1111/j.1365-2265.2006.02676.x